Phenomics Health Inc.
Phenomics Health is a pioneering precision medicine company dedicated to personalizing medication treatment through advanced pharmacogenomic and pharmacometabolomic methods. They focus on predicting the right drug and dose for various medical conditions, measuring medications in circulation, and understanding patient-specific factors to improve outcomes, reduce adverse reactions, and optimize therapy. Their innovative platform integrates genetic, biological, demographic, clinical, sociological, and environmental data to deliver highly accurate, personalized drug response predictions and recommendations.
Industries
Nr. of Employees
small (1-50)
Phenomics Health Inc.
Michigan Life Science and Innovation Center, 46701 Commerce Center Drive, Plymouth, MI 48170
Patents
Prescription decision support system and method using comprehensive multiplex drug monitoring
US-10262112-B2
View Details
Prescription decision support system and method using comprehensive multiplex drug monitoring
US-10262112-B2
View DetailsProducts
Pharmacogenomic panel (provider genomic report)
Clinical pharmacogenomic panel analyzing multiple genes and regulatory variants to inform prescribing across CNS, cardiovascular, metabolic and other therapeutic areas; sample collection via buccal swab.
Medication identification panel (binary detection, ~211 compounds)
Point-of-care fingerstick test that provides binary identification (+/-) of a broad panel of medications and OTCs and flags major drug interactions for multimorbid patients.
Behavioral-health medication quantitation panel (~87 compounds)
Assay focused on behavioral-health-related medications and OTCs that provides quantitative drug level information to enable dose optimization in psychiatry and chronic pain.
Comprehensive quantitative medication panel (232+ analytes)
Extensive quantitative assay covering hundreds of medications/analytes to support dose optimization and monitoring for metabolic, cardiovascular, pain, and psychiatric indications.
Pharmacogenomic panel (provider genomic report)
Clinical pharmacogenomic panel analyzing multiple genes and regulatory variants to inform prescribing across CNS, cardiovascular, metabolic and other therapeutic areas; sample collection via buccal swab.
Medication identification panel (binary detection, ~211 compounds)
Point-of-care fingerstick test that provides binary identification (+/-) of a broad panel of medications and OTCs and flags major drug interactions for multimorbid patients.
Behavioral-health medication quantitation panel (~87 compounds)
Assay focused on behavioral-health-related medications and OTCs that provides quantitative drug level information to enable dose optimization in psychiatry and chronic pain.
Comprehensive quantitative medication panel (232+ analytes)
Extensive quantitative assay covering hundreds of medications/analytes to support dose optimization and monitoring for metabolic, cardiovascular, pain, and psychiatric indications.
Services
Provider-facing pharmacogenomic testing and analysis using buccal swabs or genomic samples to report gene-drug associations and prescribing guidance across therapeutic areas.
Point-of-care fingerstick or lab blood testing to identify and/or quantify circulating medications and OTCs, reconcile with EMR, and detect drug-drug interactions and adherence issues.
Research services to test mechanisms, pathways, and biomarker applications for drug development and repurposing across CNS, cardiovascular, oncology, GI, and immune system disorders.
Delivery of clinical reports that reconcile measured exposures with records, identify interactions, and provide dose-tailoring recommendations to inform prescribing.
Operational support for insurance billing, claim submission, and optional prior-authorization automation through third-party integration.
Provider-facing pharmacogenomic testing and analysis using buccal swabs or genomic samples to report gene-drug associations and prescribing guidance across therapeutic areas.
Point-of-care fingerstick or lab blood testing to identify and/or quantify circulating medications and OTCs, reconcile with EMR, and detect drug-drug interactions and adherence issues.
Research services to test mechanisms, pathways, and biomarker applications for drug development and repurposing across CNS, cardiovascular, oncology, GI, and immune system disorders.
Delivery of clinical reports that reconcile measured exposures with records, identify interactions, and provide dose-tailoring recommendations to inform prescribing.
Operational support for insurance billing, claim submission, and optional prior-authorization automation through third-party integration.
Expertise Areas
- Pharmacogenomics and genomic variant interpretation
- Pharmacometabolomics and therapeutic drug monitoring
- Bioinformatics and AI-driven phenotype prediction
- Clinical laboratory testing and validation
Key Technologies
- Whole and partial genomic sequencing and variant analysis
- Analysis of non-coding/regulatory genomic variants
- Pharmacometabolomic quantitation of circulating drugs
- AI and machine learning for phenotype prediction
News & Updates
Company delivered a breakthrough investor presentation at the summit.
Advancement in precision medicine with integrated medication selection, adherence, dose tailoring, and monitoring.
Company completed validation of PrecīsMed® technology in its new CLIA lab.
Company acquired proprietary pharmacometabolomic technology to enhance its platform.
Founder Dr. Brian D. Athey presented the company's vision and activities.
Company announced the integration of six clinical products to improve medication management.
Company delivered a breakthrough investor presentation at the summit.
Advancement in precision medicine with integrated medication selection, adherence, dose tailoring, and monitoring.
Company completed validation of PrecīsMed® technology in its new CLIA lab.
Company acquired proprietary pharmacometabolomic technology to enhance its platform.
Founder Dr. Brian D. Athey presented the company's vision and activities.
Company announced the integration of six clinical products to improve medication management.